JD Health's stock soared 5.01% during intraday trading on Thursday, reflecting significant investor interest.
The surge follows the announcement of a strategic cooperation agreement between JD Health and biopharmaceutical company Everest Medicines. The partnership will focus on innovative drug new product launches, patient services, digital marketing, and internet healthcare, with Everest Medicines prioritizing its new products on the JD Health platform to improve drug accessibility and service quality.